Product Image
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. This 39-amino acid peptide has generated significant research interest for its unique dual-receptor mechanism in metabolic pathway studies.
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This 39-amino acid peptide has generated significant research interest for its unique dual-receptor mechanism, which differentiates it from single-receptor GLP-1 agonists in metabolic pathway studies.
| Molecular Weight | ~4813.45 g/mol |
| Purity | ≥98% (HPLC) |
| Physical Form | Lyophilized powder |
| Storage | -20°C, keep away from light and moisture |
Disclaimer: This product is intended for laboratory and research use only. Not for human or animal consumption. All handling should be conducted by qualified researchers in accordance with applicable regulations.
Every batch of Tirzepatide sold by CertPeptides is independently tested by a third-party laboratory. The Certificate of Analysis (COA) confirms identity, purity (≥98% via HPLC), and the absence of heavy metals and microbial contamination.
A COA is included with every order. You may also request a batch-specific COA through our contact page.